返回 Agenda
Session 3: Track B: Canadian Trends in Fostering Clinical Trial Research
Session Chair(s)
Fiona M Frappier, PHD
Senior Policy Analyst, Health Canada, Canada
The session will provide an overview of key initiatives to enhance the number and quality of trials underway in Canada. Factors impacting the clinical trials environment and opportunities to improve our healthcare innovation capabilities in Canada will be identified and described. Key outlooks will be reflected from provincial, contract research organization, and national coordinating center perspectives.
Learning Objective : At the conclusion of this session, participants should be able to:- Identify resources and tools available in the Canadian innovation ecosystem
- Discuss how to leverage strengths between industry, government, and academia
- Discuss options to further enhance Canadian clinical trials environment
Speaker(s)
Marcin Boruk, MBA, MSC
acting Director, Business Facilitation and Modernization Directorate, Health Can, Health Canada, Canada
Update on Health Canada’s Clinical Data Sharing Initiative
Janice Parente, PHD
President and CEO, Orion Human Research Accreditation, Canada
Enhancing Research Participant Protection in Canada Through Accreditation
Susan Marlin, MSC
President & CEO, Clinical Trials Ontario, Canada
Clinical Trials: The Changing Landscape - Understanding and Adapting